(S)-2-((S)-6,7-Dimethoxy-1-(4-(trifluoromethyl)phenethyl)-3,4- dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide

CAS : 2055114-67-3

Ref. 3D-FHD11467

Informations sur le produit

• Nom: (S)-2-((S)-6,7-Dimethoxy-1-(4-(trifluoromethyl)phenethyl)-3,4- dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide
• Synonymes: (αS,1S)-3,4-Dihydro-6,7-dimethoxy-N-methyl-α-phenyl-1-[2-[4-(trifluoromethyl)phenyl]ethyl]-2(1H)-isoquinolineacetamide, 2(1H)-Isoquinolineacetamide, 3,4-dihydro-6,7-dimethoxy-N-methyl-α-phenyl-1-[2-[4-(trifluoromethyl)phenyl]ethyl]-, (αS,1S)-

Description

(S)-2-((S)-6,7-Dimethoxy-1-(4-(trifluoromethyl)phenethyl)-3,4- dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide is a potent and selective histamine H3 receptor antagonist. It has shown to reduce the incidence of cataplexy in narcolepsy patients and improve wakefulness in healthy subjects. The compound was also found to be effective in the treatment of hepatic impairment. This drug interacts with the liver by inhibiting sodium-dependent glucose transport and decreasing locomotor activity. The compound also showed clinical relevance as an antidiabetic agent for the management of type 2 diabetes mellitus.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 512.6 g/mol
• Formule: C₂₉H₃₁F₃N₂O₃
• Degré de pureté: Min. 95%